Full course description

About This Course

There are numerous options for breast cancer genetic testing, with different strengths and limitations depending on the patient’s personal and family history. In this course you will practice evaluating how well a particular genetic test assesses breast cancer risk (clinical validity) and the potential impact of testing on patient outcomes (clinical utility). This course is targeted to clinicians who order breast cancer genetic testing.

CME Information and Disclosures

Jointly Provided by The Jackson Laboratory and the University of Connecticut School of Medicine
Office of Community and Continuing Medical Education

Target Audience
Practicing primary care providers as well as students and residents.

Learning Objectives

  • Determine appropriateness of genetic testing for breast cancer risk
  • Release Date

    Original Release: 6/26/15

    End Date: CME will be available until 2/28/18

    Planners, Writers, and Reviewers

    • Emily Edelman, MS – The Jackson Laboratory
    • Abdullah Elias, MD - Shodair Children's Hospital, Department of Medical Genetics
    • Greg Feero, MD, PhD - Maine General Medical Center; Maine Dartmouth Family Medicine Residency program
    • Therese Ingram, MA – The Jackson Laboratory
    • Susan Miesfeldt, MD - Maine Medical Center; Cancer Risk and Prevention Program
    • Kate Reed, MPH, ScM – The Jackson Laboratory
    • Suzanna Schott, ScM – The Jackson Laboratory, consultant
    • Robin Schwartz, MS, CGC – UCONN Health, Department of Genetics and Genome Sciences
    • Mary Lou Woodford, RN, MBA – Cancer1Source

    Accreditation: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Connecticut School of Medicine and The Jackson Laboratory. The University of Connecticut School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

    The University of Connecticut School of Medicine designates this enduring material for a maximum of .25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Conflict of Interest Policy: All faculty members participating in CME activities provided by the University of Connecticut School of Medicine are required to disclose to the program audience any actual or apparent conflict of interest related to the content of their presentations. Program planners have an obligation to resolve any actual conflicts of interest and share with the audience any safeguards put in place to prevent commercial bias from influencing the content. 

    Neither the activity director, planning committee members, nor educational developers have a financial interest/arrangement or affiliation with any organizations that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation. The program does not discuss the off-labeled use of any product.

    This CME activity is supported by educational grants from Maine Cancer Foundation and The Jackson Laboratory Director's Innovation Fund. This CME activity has no commercial support associated with it.